JPMorgan Chase & Co. Issues Positive Forecast for CME Group (NASDAQ:CME) Stock Price

Posted by Defense World Staff on Jul 24th, 2026

CME Group (NASDAQ:CME – Free Report) had its target price lifted by JPMorgan Chase & Co. from $249.00 to $250.00 in a research note published on Thursday morning,Benzinga reports. JPMorgan Chase & Co. currently has an underweight rating on the financial services provider’s stock.

Several other research analysts have also weighed in on CME. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Weiss Ratings downgraded CME Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 13th. The Goldman Sachs Group dropped their price target on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. Finally, Piper Sandler cut their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Eleven equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $291.81.

Read Our Latest Report on CME Group

CME Group Price Performance

CME opened at $254.32 on Thursday. The company has a fifty day moving average price of $255.00 and a two-hundred day moving average price of $281.41. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 52 week low of $218.31 and a 52 week high of $329.16. The firm has a market capitalization of $92.16 billion, a PE ratio of 21.57, a P/E/G ratio of 3.10 and a beta of 0.25.

CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the company earned $2.96 EPS. The company’s revenue for the quarter was up .8% compared to the same quarter last year. As a group, analysts anticipate that CME Group will post 12.17 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s dividend payout ratio is presently 44.37%.

Insider Activity

In other CME Group news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Whipplewood Advisors LLC increased its position in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares during the period. Asset Dedication LLC lifted its position in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares during the period. FNY Investment Advisers LLC bought a new stake in CME Group during the fourth quarter worth about $27,000. Elkhorn Partners Limited Partnership acquired a new stake in CME Group during the fourth quarter worth about $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in CME Group during the fourth quarter worth about $28,000. 87.75% of the stock is owned by institutional investors.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME Group beat Q2 estimates, reporting $2.99 EPS versus $2.91 expected and revenue of about $1.71 billion versus $1.68 billion expected, supporting the stock. CME profit tops estimates, CEO says ‘perps’ chatter overshadows results
Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, which likely boosted investor confidence. CME Group jumps after Q2 earnings beat and strong trading activity
Positive Sentiment: Record market data revenue and strong trading volumes suggested core business momentum remains healthy, another bullish catalyst for the stock. CME Group jumps after Q2 earnings beat and strong trading activity
Neutral Sentiment: UBS reiterated a Hold rating with a $260 target, signaling solid fundamentals but limited upside from current levels. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
Negative Sentiment: JPMorgan kept an Underweight rating and BofA maintained an Underperform stance, both implying analysts still see downside risk despite the earnings beat. Benzinga report on JPMorgan price target change Benzinga report on Bank of America price target change

CME Group Company Profile

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.